한국 아나필락시스의 진료
DESCRIPTION
Overview of anaphylaxis in Korea pediatrics 한국 아나필락시스의 진료TRANSCRIPT
- 1.
2. 3. 1. m/c, -18 9 , - . 19.4% 11.1% 11.1% 11.1% 8.3% 8.3% 5.6% 4. 2. , - m/c - m/c (41.6%)>NSAID(22.9%)>(16.7%) Older 13,552 306(2.3%), 5 0.04% gadolinium 84,367 11 0.008% , 0.0007%.62) 5. 3. m/c 4. 12 (8) > (1), (1), (1), (1) 10 20 m/c 6. 5. , 6. laminaria 7. & , , - , , , , , , , 15 > : , , , : 10 , 8. 70% -, - 30% . 90% 9. 10. 1. 1. ,, , , 11. 2. , , ,, , 12. 2. . 15~60 15~3 IgE : , . : . 13. 3. 1. , , , . 2. / , , . 3. , . , , . 4. 5. 14. 15. 1. . IM 1:1000(1mg/mL), 1 0.01mg/kg : 5~15 : continuous IV infusion : IV bolus injection , , , , , 16. 2. , . => , empty venacava/empty ventricle syndrome 17. 3. 6~8L or 4. 0.9% N/S 18. 5. H1 , , , , B2 agonist , , Steroid H2 H1 , 19. 6. , (semi-recumbent position) 20. 7. 4~6( 8~10 ) . 21. 1. 2. & IgE( 3~4 ) , Ix 22. 3. , , - - , , , - , ( )